Clinical trial
Genetic Architecture of Natriuretic Peptides and Blood Pressure Response
NCT07118592 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetic Architecture of Natriuretic Peptides and Blood Pressure Response
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- December 1, 2030
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiometabolic diseases, hypertension (htn)